Fig. 1.

Meta-analysis for VTE comparing baricitinib and TNF inhibitors showing A incidence rate ratios and B incidence rate differences. ARTIS anti-rheumatic therapy in Sweden, BKK Betriebskrankenkasse, CI confidence interval, GLMM generalized linear mixed model, HIRD HealthCore Integrated Research Database, IRR incidence rate ratio, JMDC JMDC, Inc.’s claims database, JP Japan, MDR military health system data repository, Optum® Clinformatics® Optum’s de-identified Clinformatics® Data Mart Database, PS20 private source 20, PY  person-years, RD rate difference, SNDS Système National des Données de Santé, TNFi tumor necrosis factor inhibitor, US United States, VTE venous thromboembolism. For some data sources, low counts (i.e., <11) were masked as required to maintain data privacy, as required by local regulations